• Citer

Clinically significant lower elvitegravir exposure during the third trimester of pregnant patients living with human immunodeficiency virus: Data from the pharmacokinetics of antiretroviral agents in hiv-infected pregnant women (PANNA) network

par Bukkems, Vera;Necsoi, Coca Valentina ;Tenorio, Carmen Hidalgo;Garcia, Coral;Rockstroh, Juergen;Schwarze-Zander, Caroline;Lambert, John Shearer;Burger, David;Konopnicki, Deborah ;Colbers, Angela P H
Référence Clinical infectious diseases, 71, 10, page (E714-E717)
Publication Publié, 2020-11

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Clinically significant lower elvitegravir exposure during the third trimester of pregnant patients living with human immunodeficiency virus: Data from the pharmacokinetics of antiretroviral agents in hiv-infected pregnant women (PANNA) network
Auteur:	Bukkems, Vera; Necsoi, Coca Valentina; Tenorio, Carmen Hidalgo; Garcia, Coral; Rockstroh, Juergen; Schwarze-Zander, Caroline; Lambert, John Shearer; Burger, David; Konopnicki, Deborah; Colbers, Angela P H
Informations sur la publication:	Clinical infectious diseases, 71, 10, page (E714-E717)
Statut de publication:	Publié, 2020-11
Sujet CREF:	Pathologie maladies infectieuses
	Microbiologie et protistologie [bacteriol.,virolog.,mycolog.]
	Microbiologie et protistologie [entomologie,phytoparasitolog.]
	Microbiologie et protistologie [parasitologie hum. et anim.]
Mots-clés:	Cobicistat
	Elvitegravir
	HIV
	Pharmacokinetics
	Pregnancy
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:1058-4838
	info:doi/10.1093/cid/ciaa488
	info:scp/85088375118
	info:pmid/32330231